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Abstract 51 
 52 
Both developed and developing countries are seeing increasing trends of obesity in people 53 
young and old. It is thought satiety may play a role in the prevention of obesity by increasing 54 
satiety and reducing energy intake. We hypothesized that medium chain triglycerides (MCT) 55 
would increase satiety and decrease food intake compared to conjugated linoleic acid (CLA) 56 
and a control oil. 19 healthy participants were tested on three separate occasions, where they 57 
consumed a beverage test breakfast containing either (1) vegetable oil (control) (2) CLA or 58 
(3) MCT. Participants self-requested an ad libitum sandwich buffet lunch. Time between 59 
meals, satiety from visual analogue scales (VAS), energy intake at lunch, and intake for the 60 
rest of the day using weighed food diaries were measured. The results indicated that the time 61 
until a meal request was significantly different between the three meals (p=0.016), however 62 
there were no differences in intakes at the ad libitum lunch (p>0.05). The CLA breakfast 63 
generated the greatest delay in meal time request. There was a difference between the control 64 
lipid compared to both the CLA and MCT for energy intake over the remainder of the test 65 
day and for total energy intake on the test day (p<0.001 for both), with the CLA and MCT 66 
resulting in a lower intake than the control throughout the day. There were no significant 67 
differences in satiety from VAS scores (p>0.05). Both CLA and MCT increased satiety and 68 
reduced energy intake, indicating a potential role in aiding the maintenance of energy balance. 69 
 70 
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1. Introduction 76 
 77 
According to the World Health Organisation [1], obesity has nearly doubled worldwide since 78 
1980 and obesity rates in both men and women have increased by over 10% in the UK alone 79 
since 1993 [2]. Obesity can develop into a major health problem increasing the risk of 80 
developing numerous diseases, including type II diabetes, cardiovascular disease and 81 
premature death [3]. The leading causes of obesity are lack of physical activity and 82 
overconsumption of high energy food [4]. With individuals and governments searching for 83 
different solutions to weight loss and fat reduction, the use of dietary supplements has 84 
increased significantly in recent years [5] [6]. It is possible that satiety may play a key role in 85 
the development of obesity [7]. 86 
 87 
Benelam [8] defines satiety as “the feeling of fullness that persists after eating, potentially 88 
suppressing further energy intake until hunger returns”. It is possible that increasing satiety, 89 
and thus, delaying the onset of food intake can lead to less food intake at the next meal and 90 
throughout the rest of the day. If food intake is lowered then the risk of obesity will 91 
potentially reduce. It is possible that certain foods can play a role in increasing satiety, and 92 
thus, reduce overall food intake. At the very least they may encourage individuals to be less 93 
distracted by cues to consume, and enable them to maintain regular eating habits [9]. 94 
 95 
Conjugated linoleic acid (CLA) refers to a class of positional and geometric conjugated 96 
dienoic isomers of linoleic acid that is naturally present in the meat of ruminants. Cis-9, 97 
trans-11 CLA and trans-10, cis-12 make up the main isomers of CLA [10]. CLA is believed 98 
to have a positive effect on human health, particularly on body weight and body fat [11]. It is 99 
thought that the isomer trans-10, cis-12 is responsible for positive changes in body 100 
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composition [10]. Some studies have shown that daily intake of CLA can reduce both body 101 
weight and body fat [12-14] though the clinical relevance of these changes is still open to 102 
debate [15]. There has been little research conducted on the effects of CLA on satiety. 103 
Several studies have assessed the effect of CLA on appetite [16-18]. However this research 104 
has primarily focused on subjective ratings of appetite or following a CLA intervention. To 105 
the authors knowledge no data has examined the effect on actual food intake during a one day 106 
trial. In rats however, some studies found decreased energy intakes following CLA 107 
consumption [19-21] whereas other studies observed no effect on food intake [22-24]. It is 108 
known that intake of CLA decreases the uptake of fatty acids into adipocytes and increases β-109 
oxidation in muscle cells. A potential theory is that this may result in a shift towards fat 110 
oxidation that could result in glycogen being spared. This may in turn serve as a satiety 111 
signal, as has been proposed by several researchers [25, 26]. However this mechanism has 112 
not been proved in other research [27, 28] so speculation as to how CLA can increase satiety 113 
remains open to debate. Studies on medium-chain triglycerides have been much more 114 
frequent.  115 
 116 
Medium-chain triglycerides (MCTs) are triglycerides with a fatty acid chain length varying 117 
between 6 and 10 carbon atoms. MCTs are soluble in water, rapidly absorbed and 118 
preferentially oxidised compared to long-chain triglycerides (LCTs). The most common 119 
sources of MCTs are coconut oil, palm oil and dairy fat; however it is most commonly used 120 
as a weight loss aid in the form of synthetic oil [29] where over 16 weeks it has been shown 121 
to result in greater weight losses than olive oil (-1.67 +/- 0.67 kg) [30]. MCT has 122 
demonstrated it’s ability to increase satiety by delaying meal requests and reducing food 123 
intake by up to 698kJ compared to a saturated lipid [31]. MCTs ability to increase satiety is 124 
believed to be due to its increased oxidative capacity; however the exact mechanisms are 125 
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unknown. MCTs undergo nearly complete hydrolysis to free fatty acids (FFA) after ingestion, 126 
and are then absorbed directly into the portal vein. Then they are transported rapidly to the 127 
liver for β-oxidation. LCTs, differ however, as they are absorbed via the intestinal lymphatic 128 
ducts at a much slower rate and transported by chylomicrons into the systemic circulation 129 
prior to oxidation or storage. MCTs are faster oxidised than LCTs [32]. Therefore they are a 130 
much more readily available energy source. Several studies have been unable to detect 131 
differences in satiety following MCT [33, 34] , however other studies have shown  MCT’s 132 
can be beneficial to increasing satiety and reducing energy intake, and thus, causing weight 133 
loss [35]. However, how different lipids compare in terms of their ability to increase satiety is 134 
less well known. 135 
 136 
The objectives of this study were twofold. Firstly, to examine the effect of CLA on satiety 137 
and food intake. To the author’s knowledge this has not previously been completed in a 138 
single day trial assessing food intake and subjective satiety. The second objective of this 139 
study was to compare the effect of CLA to MCT in terms of satiety and food intake. The 140 
authors hypothesize that MCT will increase satiety more than CLA or a control lipid. The 141 
methods used to measure satiety in this study included a self-requested ad libitum buffet 142 
lunch and visual analogue scales. 143 
 144 
2. Methods and materials 145 
 146 
2.1.Participants 147 
 148 
Participants were recruited through the use of posters, social networking and word of mouth. 149 
Prior to participation all participants were tested for suitability through both a pre-test 150 
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questionnaire and a dietary restraint questionnaire [36]. Twenty-six participants were 151 
recruited in total. Eating behaviour was determined using the Dutch eating behaviour 152 
questionnaire [37]. Only those who did not consciously restrain their food intake due to 153 
psychological reasons, weight concerns and external stimuli were included in the study. 154 
Those who fulfilled all the acceptable criteria (age 18-60 years; body mass index <30 kg/m2; 155 
blood pressure 110-120/75-85 mmHg; non-smoking; not highly physically active or involved 156 
in sports at the endurance and competitive levels (>10 hours a week vigorous exercise); not 157 
suffering from any eating disorders; not allergic/intolerant to any of the foods presented in the 158 
study; habitually consuming breakfast and lunch; not on prescription medication; no genetic 159 
or metabolic diseases) were included in the study. On the day before each test, participants 160 
were asked to restrict their intake of alcohol and caffeine containing drinks and to refrain 161 
from strenuous physical activity. 162 
All participants were given an information sheet explaining the study and the possible risks to 163 
taking part prior to giving informed consent. Ethical approval was granted by the Research 164 
Ethics officer at Oxford Brookes University in line with the Declaration of Helsinki. 165 
Participants were asked to fast for 12 hours prior to testing and to not do any strenuous 166 
exercise the morning of the test. 19 participants (12f; 31.4 ± 18.0 yr; 169 ± 11 cm; 68.6 ± 167 
11.7 kg) completed the study (figure 1).  168 
    169 
2.2. Experimental design 170 
 171 
Participants took part in a randomised, single blind study. Participants were required to attend 172 
the laboratory from 9am to 2pm on three separate non-consecutive days. Participants 173 
consumed a test breakfast containing CLA, MCT or a control oil (vegetable oil), following 174 
which their appetite and satiety were monitored. Prior to the first test participants recorded 175 
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the previous day’s food intake using a weighed food diary and repeated this food intake on 176 
the day prior to the subsequent tests. 177 
 178 
2.3. Breakfast 179 
 180 
The test breakfast consisted of 250ml of Tesco red berries smoothie - 123 kcal (515 kJ), 0.8 g 181 
protein, 29.8 g carbohydrate, 27.0 g sugar and 0 g fat. Added to it was 193 kcal (808kJ) of 182 
lipids, consisting of either 5 g CLA (Trec Nutrition, London, UK) and 16g vegetable oil, 25 g 183 
MCT (Trec Nutrition, London, UK) or 22 g vegetable oil as a control (Tesco, Cheshunt, UK). 184 
All lipids were added in these doses so that smoothies had the same energy and fat content. 185 
The total energy content of each smoothie was 316 kcal (1323kJ). Doses used for each lipid 186 
was based on previous studies, considered safe and sufficient enough to see a possible effect 187 
[14, 38]. Pretesting was undertaken to ensure that the three drinks tasted similar and palatable. 188 
 189 
2.4.Subjective satiety 190 
 191 
Satiety was measured using visual analogue scales (VAS). Participants were asked to fill out 192 
a 100mm VAS before and after the test breakfast. The VAS were anchored at the left and 193 
right ends with opposing statements for feelings of hunger, fullness, desire to eat and 194 
prospective food consumption. The specific questions asked were, ‘How hungry do you 195 
feel?’, ‘How full do you feel?’, ‘How strong is your desire to eat?’ and ‘How much food do 196 
you think you can eat?’. The VAS contained numbers ranging from 1-10, with 1 being low 197 
and 10 being high. The VAS were completed by participants every half hour after the 198 
breakfast up until the participant felt hungry enough to request lunch. The time taken between 199 
breakfast and the request for lunch was measured for each participant as previously 200 
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undertaken by Van Wymelbeke et al [31]. Because the participants requested their lunches 201 
and dinners at different times, the scores given in the VAS were analysed up to 60 minutes as 202 
this was the time at which the first person requested their lunch.  This was the method 203 
previously used by Van Wylebeke et al [31]. Participants were allowed 500ml of water 204 
during the time between breakfast and lunch on the first test. This was measured and repeated 205 
in subsequent tests. 206 
 207 
2.5. Food intake 208 
 209 
Participants were asked to let the researchers know when they felt hungry enough to eat lunch 210 
following the test breakfast. Participant had to stay in the laboratory until 2pm regardless of 211 
how soon they requested their ad libitum lunch. All time cues were removed from the 212 
participants view – clocks on laptops were covered with paper and tape and phones and 213 
watches were removed. Once lunch was requested, sandwiches were given ad-libitum to 214 
measure food intake similar to that used by Ranawana et al [39] and Clegg and Thondre [40]. 215 
Prior to testing participants were given a choice of sandwiches from a list prior to testing and 216 
asked to choose which ones they liked. All the sandwich recipes were formulated to contain 217 
the same energy content per portion (Table 1). The lunch consisted of three weighed plates 218 
each containing two sandwiches cut into quarters. Participants were given all the sandwiches 219 
at once so that it was in excess and asked to eat until they felt comfortably full. Participants 220 
were given the same sandwiches for each test. The subjects were presented with the meal 221 
under identical conditions on each test day. They ate in the same laboratory on their own with 222 
no distractions and were given 30 minutes in which to eat their ad libitum meal.  223 
 224 
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When participants finished eating and the remaining food leftover was weighed to measure 225 
food intake. A food diary was used to measure food intake for the rest of the day. Food 226 
diaries were analysed using the software package Nutritics Professional (Est. 2011, Dublin, 227 
Ireland).  228 
 229 
2.6. Statistical analyses 230 
 231 
Statistical analyses was performed using Statistical Package for the Social Sciences (version 232 
20.0; SPSS, Chicago, IL, USA) and data and figures were processed using Microsoft Excel 233 
(2006, Reading, UK). A power calculation was conducted for the primary outcome measure 234 
of energy intake. A sample size of 19 was required to detect a 300 kJ difference in energy 235 
intake with a standard deviation of 250kJ and α set at 0.05 and a power of 90% [31]. 236 
 237 
A repeated measures ANOVA with Bonferroni correction was performed on the food intake 238 
and time-to-meal-request data to gage if there were any significant differences in satiety 239 
levels between lipids. A repeated measures ANCOVA was used for analysis of the VAS data 240 
up to and including the 60 minute data. The baseline was used as a covariate in the analysis. 241 
The significance value was set at p<0.05. 242 
 243 
3. Results 244 
 245 
3.1.Ad libitum lunch 246 
 247 
For the ad libitum lunch (Table 2) there were no significant differences in intake between the 248 
control, CLA or MCT tests on energy or any macronutrients (p>0.05). Energy and 249 
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macronutrient intake was highest amongst the control group, an average of 70 kcal (293kJ) 250 
more than CLA and MCT. Macronutrient intake was similar after consumption of both CLA 251 
and MCT at lunch. 252 
 253 
3.2.Rest of day intake 254 
 255 
There were significant differences in food intake from the rest of the day (Table 2) following 256 
the ad libitum lunch between the three meals (p<0.001). These differences were found 257 
between the MCT meal and the control, and between the CLA meal and the control. The 258 
MCT breakfast resulted in the least amount of energy consumed after lunch and the control 259 
had the highest intake, with an average of 471 kcal (1972 kJ) more consumed following the 260 
control compared to CLA and 525 kcal (2198 kJ) more compared to MCT. There were also 261 
significant differences in intake of all macronutrients following the three breakfasts (protein 262 
p=0.003, fat p<0.001; carbohydrate p<0.001). These differences were found between the two 263 
test lipids and the control for all three macronutrients with the exception of protein, in which 264 
the CLA was not significantly different to the control.  265 
 266 
3.3.Total days intake  267 
 268 
The results showed that having the control breakfast resulted in the greatest energy intake, an 269 
average of 541 kcal (2265 kJ) more compared to CLA and 594 kcal (2487 kJ) more than 270 
MCT (p<0.001). There were significant differences following the control compared to CLA 271 
and MCT for total energy intake and on all macronutrient intakes with the exception of 272 
protein between the control and the CLA breakfast. The MCT showed the greatest satiating 273 
effect.  274 
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3.4.Time until meal request 276 
 277 
The time until a meal request (Table 3) showed that there was a significant difference in the 278 
time until lunch was requested between the three meals (p=0.016). These differences existed 279 
between the control breakfast and the CLA breakfast (p=0.049). The control delayed the meal 280 
request the least, followed by the MCT with the CLA delaying the time until lunch the most.   281 
 282 
3.5.Visual analogue scale  283 
 284 
There were no significant differences between any of the three tests on any of the four 285 
questions hunger, fullness, desire to eat or prospective consumption (p>0.05; Figure 2). 286 
Perceived satiety increased immediately following the breakfast and then decreased again at 287 
30 and 60 minute. 288 
 289 
4. Discussion 290 
 291 
As far as the authors of this study are aware, this is the first study that has compared the 292 
effect of both CLA and MCTs on food intake and satiety within the same study. The results 293 
from this study show that both CLA and MCTs reduce and delay food intake over a day when 294 
compared to a control. The results showed that there were significant differences in time to 295 
lunch request, energy and macronutrient intakes for the rest of the day (after test breakfast 296 
and ad libitum lunch) and over the entire day between the three meals. These differences 297 
were seen between the CLA and MCT compared to the control. There were no significant 298 
differences between CLA and MCT intakes at any stage or for any parameter. These results 299 
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show that both test lipids increased satiety and thus reduced energy intake hence rejecting the 300 
original hypothesis that only MCT would increase satiety above the control.  301 
 302 
Data on CLA and satiety is limited. One previous study [18]  found that CLA did not reduce 303 
ad libitum energy intake during breakfast after consuming a dose of either 1.8g or 3.6g per 304 
day and after an overnight fast, though feelings of fullness and satiety were increased and 305 
feelings of hunger were decreased compared to placebo. However, this study was looking at 306 
the effect of a 13 week CLA intervention and CLA had not been consumed since the day 307 
before. This may indicate that the results are due to long term dietary changes rather than the 308 
effect of a single dose of CLA. A similar study conducted by Lambert et al. [17] found no 309 
significant reduction in subjective satiety ratings after a standardised breakfast following 310 
CLA supplementation for 12 weeks. The current study was able to demonstrate the effect of a 311 
single dose of CLA on meal request and food intake.  312 
 313 
In contrast to CLA the short term effects of MCTs are well documented, showing a decreased 314 
intake at lunch following an MCT rich breakfast [31, 41]. However the current study did not 315 
find a difference in food intake at lunch or a significant delay in the meal request, though this 316 
did approach significance. It is possible taking a dose of at least 25g of MCTs in the morning 317 
can reduce energy intake later in the day i.e. after lunch. This result is similar to that in other 318 
studies where intake of MCT reduced energy intake later in the day [42] , and research that 319 
showed that food intake at dinner was reduced following an MCT lunch but similar to the 320 
current study the meal request was not delayed [43]. Interestingly the current study was not 321 
able to detect any difference in satiety between the two test lipids indicating that they both 322 
were equally as satiating as the other. 323 
 324 
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For the ad libitum lunch, there were no significant differences in intakes between CLA, MCT 325 
or the control. However this may be due to the meal request being earlier following the CLA 326 
and MCT and may indicate that the participants were truly able to detect their level of hunger 327 
and accurately compensate for this. The methods used were chosen to test the possibility that 328 
the test lipids allow a longer time period between breakfast and lunch. Had participants been 329 
given lunch at a set time, it would not have allowed the possibility to test the duration of 330 
satiety. It was decided that participants would be taken into the laboratory in the morning, 331 
given the test breakfast, and sent back out to a waiting area. There was no set time for lunch 332 
and participants were told to tell the researchers when they felt hungry enough to eat lunch, 333 
which worked efficiently in a previous study [31]. Participants were told they were to be in 334 
the laboratory from 9 a.m. to 2 p.m. This eliminated the temptation to request lunch in order 335 
to be able to leave the laboratory prior to feeling genuine hunger. If participants finished 336 
lunch prior to 2 p.m. they were asked to wait in the laboratory until then. Participants were 337 
asked to fill out food diaries for the rest of the day after the ad libitum lunch. Although this 338 
was aimed to replicate a free -living element to the study it is known that people often 339 
underestimate their food intake when filling out food diaries or don’t eat as they normally 340 
would as they know they are recording it [44] which could impact on the results. 341 
 342 
Nausea, stomach cramping and other gastrointestinal problems are a known side effect of 343 
MCTs [35]. Five participants in the present study reported suffering side effects of this nature 344 
after ingesting the MCT breakfast. This shows that even a dose as small as 25g of MCTs can 345 
have side effects which may have impacted in their food intake. One participant suffered 346 
gastrointestinal discomfort from ingesting the CLA. There were no side effects from 347 
ingesting the control.  348 
 349 
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There were several limitations to this study. The use of food diaries as highlighted previously 350 
does not control the environment in which the participant is tested, however they do have 351 
their merits including high external validity and applicability to real life situations  [45]. The 352 
two test lipids were not matched in terms of energy content due to a compromise between 353 
seeing positive results and not having adverse effects on the participants. Instead doses were 354 
chosen based on previous literature. Although pretesting was completed in a different 355 
population, no direct measures of palatability were completed in the current volunteers so 356 
they would not be concerned about differences between the beverages. However there is a 357 
chance that the current cohort of volunteers was able to detect differences that might have 358 
influenced their palatability and intake. GI disturbances were not recorded during the study 359 
but the participant was asked about these after each day so as not to influence their thoughts 360 
on this issue. Finally each individual had the same sandwiches for all three of their ad libitum 361 
meals which may have become monotonous and caused sensory specific satiety however the 362 
volunteers were given sandwiches to suit their preferences. Johnson and Vickers[46] have 363 
previously outlined that there is a trend for less-liked test meals to drop more in liking than 364 
the well-liked test meals following repeated exposure. 365 
 366 
The present study reveals that both CLA and MCT can increase satiety and decrease food 367 
intake over a period of a day. Given the side effects seen following MCT consumption and 368 
that CLA consumption resulted in had similar satiating effects, CLA may be proposed as an 369 
alternative food ingredient to increase satiety. This may be beneficial to future prevention 370 
and/or treatment of obesity; however more research is needed including longer duration 371 
laboratory trials particularly on CLA and its effect on satiety and food intake. 372 
 373 
 374 
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Figure 1: Flow chart showing participant recruitment 528 
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26 potential participants 
initially recruited 
5 volunteers were eliminated 
due to being restrained eaters 
2 participants 
dropped out 
19 participants 
completed the study 
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Figure 2: Visual analogue scale data for hunger, fullness, desire to eat and prospective 553 
consumption at baseline (0 min), after breakfast (post break), and 30 and 60 min after 554 
breakfast a. 555 
 556 
a Values are means ± SD 557 
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Table 1: Nutritional content of sandwiches (ad libitum lunch)a.   578 
Sandwich: Weight (g) Energy (kcal (kJ)) Carbohydrate (g) Protein (g) Fat (g) 
Egg mayo 223 408.20 (1709) 36.68 17.46 19.81 
Cheese and 
tomato 
 
185 
 
406.06 (1700) 
 
36.62 
 
19.73 
 
18.51 
Tuna mayo 146 402.79 (1686) 35.30 18.37 19.56 
Chicken salad 221 406.48 (1701) 37.51 18.61 18.66 
Cheese and 
pickle 
 
148 
 
404.75 (1695) 
 
38.98 
 
19.03 
 
17.75 
Ham and 
cheese 
 
153 
 
405.43 (1698) 
 
35.62 
 
21.49 
 
18.21 
Roast beef and 
tomato 
 
181 
 
404.30 (1693) 
 
36.55 
 
20.02 
 
18.11 
 579 
a Three plates of sandwiches were served at each ad libitum lunch 580 
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Table 2: Energy and macronutrient intake at the ad libitum lunch, for the rest of the day 591 
following the lunch and the day’s total intake a, b, c 592 
  Control CLA MCT 
Ad Libitum Lunch 
Energy (kcal) 
kJ 
798.45 ± 207.91 
3343 ± 870 
728.61 ± 188.38 
3051 ± 789 
728.73 ± 182.91 
3051 ± 766 
Carbohydrate (g) 71.87 ± 19.27 65.38 ± 16.51 65.40 ± 16.12 
Protein (g) 37.90 ± 10.24 34.43 ± 8.53 34.48 ± 8.51 
Fat (g) 36.73 ± 9.36 33.73 ± 9.45 33.72 ± 9.06 
Rest of day intake 
Energy (kcal) 
kJ 
1171.63 ± 458.36  
4905 ± 1919 
699.95  ± 321.49* 
2931 ± 1346 
646.74 ± 313.75* 
2708 ± 1314 
Carbohydrate (g) 124.32 ± 60.48 69.74 ± 42.60* 64.08 ± 41.56* 
Protein (g) 65.05 ± 30.41 47.79 ± 23.01 44.49 ± 20.55* 
Fat (g) 39.85 ± 16.82 23.63 ± 13.76* 21.68 ± 13.04* 
Total days intake 
Energy (kcal) 
kJ 
1970.08 ± 666.27 
8248 ± 2790 
1428.56 ± 509.87* 
5891 ± 2135 
1375.46 ± 496.67* 
5759 ± 2080 
Carbohydrate (g) 196.18 ± 79.75 135.12 ± 59.12* 129.49 ± 57.67* 
Protein (g) 102.96 ± 40.66 82.22 ± 31.54 78.97 ± 29.05* 
Fat (g) 76.58 ± 26.18 57.36 ± 23.21* 55.40 ± 22.10* 
 593 
* p<0.05 compared to control 594 
a Values are means ± SD 595 
26  
b n=19 596 
c Data analysed using RM-ANOVA  597 
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Table 3: Time until meal request a, b, c, d. 621 
 Control CLA MCT 
Time (minutes) 142.11 ± 42.25 181.58 ± 61.15* 167.37 ± 40.50 
  622 
* p<0.05 compared to control 623 
a Data is given in minutes for all tests for total time between the test breakfast and when 624 
participants asked for lunch 625 
b Values are means ±SD 626 
c n=19 627 
d Data analysed using RM-ANOVA  628 
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